Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review

OBJECTIVES: Sustained hepatitis B surface antigen (HBsAg) loss or ‘functional cure’ (FC) is considered an optimal treatment endpoint by international clinical guidelines for chronic hepatitis B (CHB), yet rarely is this achieved with current standard of care (SoC). This leads to an under-reporting o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wigfield, Peter, Sbarigia, Urbano, Hashim, Mahmoud, Vincken, Talitha, Heeg, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426349/
https://www.ncbi.nlm.nih.gov/pubmed/31428938
http://dx.doi.org/10.1007/s41669-019-00175-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426349/
https://www.ncbi.nlm.nih.gov/pubmed/31428938
http://dx.doi.org/10.1007/s41669-019-00175-w

Ejemplares similares